Carnitine palmitoyltransferase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='2rcu' size=' | + | <StructureSection load='2rcu' size='350' side='right' scene='48/485614/Cv/1' caption='Rat carnitine palmitoyltransferase II dimer complex with substrate analog and octylglucoside (PDB code [[2rcu]])'> |
__TOC__ | __TOC__ | ||
== Function == | == Function == | ||
| Line 14: | Line 14: | ||
CPT I contains an extra ca. 160 amino acids domain at its N terminal. <scene name='48/485614/Cv/2'>Substrate analog interacts with CPT II</scene> [[2rcu]] in a <scene name='48/485614/Cv/4'>large tunnel</scene> with its <scene name='48/485614/Cv/5'>hydrophilic head group</scene> situated at the tunnel center and the <scene name='48/485614/Cv/6'>alkyl part occupying the hydrophobic part</scene> of the tunnel. <ref>PMID:17585909</ref> | CPT I contains an extra ca. 160 amino acids domain at its N terminal. <scene name='48/485614/Cv/2'>Substrate analog interacts with CPT II</scene> [[2rcu]] in a <scene name='48/485614/Cv/4'>large tunnel</scene> with its <scene name='48/485614/Cv/5'>hydrophilic head group</scene> situated at the tunnel center and the <scene name='48/485614/Cv/6'>alkyl part occupying the hydrophobic part</scene> of the tunnel. <ref>PMID:17585909</ref> | ||
| - | + | </StructureSection> | |
==3D structures of carnitine palmitoyltransferase== | ==3D structures of carnitine palmitoyltransferase== | ||
| Line 25: | Line 25: | ||
[[2le3]] – hCPT I regulatory domain – human - NMR<br /> | [[2le3]] – hCPT I regulatory domain – human - NMR<br /> | ||
[[2m76]] - hCPT I regulatory domain – NMR<br /> | [[2m76]] - hCPT I regulatory domain – NMR<br /> | ||
| - | + | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:50, 6 December 2015
| |||||||||||
3D structures of carnitine palmitoyltransferase
Updated on 06-December-2015
2h4t, 2fyo, 2deb – rCPT II – rat
2fw3 - rCPT II + antidiabetic drug
2rcu – rCPT II + substrate analog
4ep9, 4eph, 4eyw - rCPT II + inhibitor
2le3 – hCPT I regulatory domain – human - NMR
2m76 - hCPT I regulatory domain – NMR
References
- ↑ Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520. PMID:15363638 doi:http://dx.doi.org/10.1016/j.mam.2004.06.004
- ↑ Rufer AC, Lomize A, Benz J, Chomienne O, Thoma R, Hennig M. Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog. FEBS Lett. 2007 Jul 10;581(17):3247-52. Epub 2007 Jun 8. PMID:17585909 doi:10.1016/j.febslet.2007.05.080
